Cefcapene

DB13461

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 453.49
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

796 Data
Probenecid The serum concentration of Cefcapene can be increased when it is combined with Probenecid.
Foscarnet The risk or severity of nephrotoxicity can be increased when Cefcapene is combined with Foscarnet.
Mannitol The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Cefcapene.
Tenofovir disoproxil Cefcapene may increase the nephrotoxic activities of Tenofovir disoproxil.
Tenofovir alafenamide Cefcapene may increase the nephrotoxic activities of Tenofovir alafenamide.
Tenofovir Cefcapene may increase the nephrotoxic activities of Tenofovir.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefcapene.
Cyclosporine The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefcapene.
Icosapent The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Cefcapene.
Cefotiam The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Cefcapene.
Mesalazine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefcapene.
Cefmenoxime The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Cefcapene.
Cefmetazole The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Cefcapene.
Indomethacin The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefcapene.
Triamterene The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefcapene.
Cefpiramide The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Cefcapene.
Loracarbef The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cefcapene.
Cefalotin The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Cefcapene.
Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefcapene.
Ketorolac The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefcapene.
Tenoxicam The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Cefcapene.
Celecoxib The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Cefcapene.
Cefotaxime The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefcapene.
Tolmetin The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Cefcapene.
Rofecoxib The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Cefcapene.
Fenoprofen The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Cefcapene.
Valdecoxib The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefcapene.
Diclofenac The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Cefcapene.
Sulindac The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Cefcapene.
Bacitracin The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Cefcapene.
Amphotericin B The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefcapene.
Cephaloglycin The risk or severity of nephrotoxicity can be increased when Cephaloglycin is combined with Cefcapene.
Adefovir dipivoxil The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Cefcapene.
Pentamidine The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Cefcapene.
Mefenamic acid The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Cefcapene.
Naproxen The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefcapene.
Sulfasalazine The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefcapene.
Phenylbutazone The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Cefcapene.
Meloxicam The risk or severity of methemoglobinemia can be increased when Cefcapene is combined with Meloxicam.
Carprofen The risk or severity of nephrotoxicity can be increased when Carprofen is combined with Cefcapene.
Tacrolimus The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Cefcapene.
Etacrynic acid The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Cefcapene.
Ceforanide The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Cefcapene.
Salicylic acid The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Cefcapene.
Acetylsalicylic acid The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefcapene.
Hydrochlorothiazide The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefcapene.
Balsalazide The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Cefcapene.
Cefditoren The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Cefcapene.
Atazanavir The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefcapene.
Colistimethate The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Cefcapene.
Cefuroxime The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Cefcapene.
Cefapirin The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Cefcapene.
Cefprozil The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Cefcapene.
Olsalazine The risk or severity of nephrotoxicity can be increased when Cefcapene is combined with Olsalazine.
Lumiracoxib The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Cefcapene.
Cefamandole The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Cefcapene.
Cefazolin The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Cefcapene.
Cefonicid The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Cefcapene.
Cefoperazone The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Cefcapene.
Cefoxitin The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Cefcapene.
Ceftizoxime The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Cefcapene.
Magnesium salicylate The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Cefcapene.
Salsalate The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Cefcapene.
Choline magnesium trisalicylate The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Cefcapene.
Cefepime The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Cefcapene.
Cefacetrile The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Cefcapene.
Cefpodoxime The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Cefcapene.
Antrafenine The risk or severity of nephrotoxicity can be increased when Antrafenine is combined with Cefcapene.
Aminophenazone The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Cefcapene.
Antipyrine The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Cefcapene.
Tiaprofenic acid The risk or severity of nephrotoxicity can be increased when Tiaprofenic acid is combined with Cefcapene.
Lopinavir The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Cefcapene.
Etoricoxib The risk or severity of nephrotoxicity can be increased when Etoricoxib is combined with Cefcapene.
Hydrolyzed Cephalothin The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Cefcapene.
Cephalothin Group The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Cefcapene.
Oxyphenbutazone The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Cefcapene.
Latamoxef The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Cefcapene.
Nimesulide The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Cefcapene.
Benoxaprofen The risk or severity of nephrotoxicity can be increased when Benoxaprofen is combined with Cefcapene.
Metamizole The risk or severity of nephrotoxicity can be increased when Metamizole is combined with Cefcapene.
Zomepirac The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Cefcapene.
Ceftobiprole The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Cefcapene.
Cimicoxib The risk or severity of nephrotoxicity can be increased when Cimicoxib is combined with Cefcapene.
Ceftaroline fosamil The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Cefcapene.
Lornoxicam The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Cefcapene.
Zaltoprofen The risk or severity of nephrotoxicity can be increased when Zaltoprofen is combined with Cefcapene.
Azapropazone The risk or severity of nephrotoxicity can be increased when Azapropazone is combined with Cefcapene.
Parecoxib The risk or severity of nephrotoxicity can be increased when Parecoxib is combined with Cefcapene.
Salicylamide The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Cefcapene.
Kebuzone The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Cefcapene.
Isoxicam The risk or severity of nephrotoxicity can be increased when Isoxicam is combined with Cefcapene.
Indoprofen The risk or severity of nephrotoxicity can be increased when Indoprofen is combined with Cefcapene.
Ibuproxam The risk or severity of nephrotoxicity can be increased when Ibuproxam is combined with Cefcapene.
Floctafenine The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Cefcapene.
Fenbufen The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefcapene.
Etofenamate The risk or severity of nephrotoxicity can be increased when Etofenamate is combined with Cefcapene.
Epirizole The risk or severity of nephrotoxicity can be increased when Epirizole is combined with Cefcapene.
Cefaloridine The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Cefcapene.
Cefminox The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Cefcapene.
Dexibuprofen The risk or severity of nephrotoxicity can be increased when Dexibuprofen is combined with Cefcapene.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul